Susan Hasty, Publisher
Table of Contents . . . September 29th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Dementia - Novel CXCR4 antagonist may prevent HIV-induced neurotoxicity
HIV/AIDS Therapy - Lopinavir-ritonavir regimens reduce methadone efficacy
HIV/AIDS Therapy - Baseline immune markers do not predict discordant antiretroviral treatment responses
HIV/AIDS Therapy - Drug levels in untimed plasma samples predict treatment outcome in advanced HIV patients
Immunology - CD44 mediates CCL5-induced cell activation and HIV infectivity enhancement
Opportunistic Infection - Bartonella infection common in advanced HIV infection
AIDS Epidemiology - Russian officials report rise in HIV cases
AIDS Epidemiology - WHO warns of wider HIV/AIDS epidemic in Asia-Pacific amid rise in STDs
AIDS Prevention - Bacteria may show promise in AIDS fight
AIDS Therapy - Biopharma inks agreement with Guangdong Medicine Group Corp.
AIDS Therapy - DHHS panel recommends Kaletra as part of protease inhibitor-based regimen
Cachexia - Drug receives FDA approval to treat HIV-associated wasting and cachexia
Cachexia - Par Pharmaceutical announces agreement with Bristol-Myers Squibb for Megace
Diagnostics - One-step HIV test may be cheaper, faster, less wasteful
Finance - Dawson James Securities initiates coverage of HIV vaccine developer
HIV Entry Inhibition - Phase I trial initiated for new anti-HIV drug candidate AMD070
HIV Prevention - HIV seen as less threatening in era of new treatments
HIV Prevention - Phase I testing of HIV microbicide initiated
HIV Progression - Disease development can be monitored and predicted
HIV Therapy - Phase I trial of autologous VRX496 modified T cells deemed safe
HIV/AIDS Cancer - In age of HAART, HIV status no longer affects NSCLC mortality risk
HIV/AIDS Dyslipidemia - Mechanisms underlying hypertriglyceridemia in HIV patients elucidated
HIV/AIDS Neurotoxicity - HIV infection impairs astrocyte glutamate transport
HIV/AIDS Pathogenesis - CD4 dependence of gp120IIIB-CXCR4 interaction varies by cell type
HIV/AIDS Pathogenesis - Intestinal cell cycle dysregulation occurs during SIV infection
HIV/AIDS Pathogenesis - Vav prevents HIV Nef-induced GM1 downregulation and NF-AT inhibition
HIV/AIDS RNA Research - Tat acetylation needed for CyclinT1-independent HIV transactivation
HIV/AIDS Therapy - Didanosine remains active against HIV strains with M184V/I mutation
HIV/AIDS Therapy - Lipid-lowering drug use rising in PI-treated HIV patients
HIV/AIDS Therapy - Stavudine treatment, low CD4 cell counts are hypothyroidism risk factors in HIV patients
HIV/AIDS Transmission - HIV PEP education needed for U.S. emergency room workers
Hepatitis B Risk Factor - Prevalence of hepatitis B infection high in HIV-infected subjects
Infectious Disease - AIDS, malaria, and TB greatest threats to human security, official says at UN
Information Technology - New Web site for HIV-positive women
Legal Issues - Brazil takes first step toward breaking patents on AIDS drugs
Opportunistic Infection - Interleukin-15 plays key role in response to invasive aspergillosis
Perinatal HIV Transmission - Researchers describe simple way to reduce HIV transmission from mom to baby
Personnel - Neuropathy drug company names Dr. Thorsten von Stein as chief medical officer
Personnel - Zolla-Pazner joins viral advisory board at biotech company
RNA Research - N- and C-terminal zinc fingers in HIV NC protein have different roles
Therapeutic Vaccines - Update provided on HIV, cancer vaccines, workforce reduction
West Nile Virus - Deal signed to share development of West Nile virus hyperimmune globulin
Women's Health - HIV-2 raises cervical HSIL risk in African women
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.